News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

INEX Pharmaceuticals (IEX.TO) Conference Call Advisory - 2006 Year End Operating Results



3/20/2007 3:54:32 PM

VANCOUVER, March 20 /PRNewswire-FirstCall/ - Inex Pharmaceuticals Corporation announced today that it will hold a conference call and webcast on Wednesday March 21, 2007 at 9:00 am PST (12:00 noon EST) to discuss 2006 year end operating results and to provide an update on developments at the Company.

About the Conference Call

To participate in the conference call, please dial 416-641-6115 or 1-866-542-4241. The call will be available for replay until March 28, 2007 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3217983.

The live or archived webcast can also be accessed through the Company's website at www.inexpharm.com.

About INEX

INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. Further information about INEX and this news release can be found at www.inexpharm.com.

INEX's common shares are traded on the Toronto Stock Exchange under the trading symbol "IEX".

CONTACT: Contacts for Inex Pharmaceuticals Corporation: Investors: Ian Mortimer, Vice President, Finance and Chief Financial Officer, Phone: (604) 419-3200; Media: Karen Cook Boas, James Hoggan & Associates Inc., Phone: (604) 739-7500, Email: kcook@hoggan.com

Inex Pharmaceuticals Corporation

CONTACT: Contacts for Inex Pharmaceuticals Corporation: Investors: IanMortimer, Vice President, Finance and Chief Financial Officer, Phone: (604)419-3200; Media: Karen Cook Boas, James Hoggan & Associates Inc., Phone:(604) 739-7500, Email: kcook@hoggan.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES